Skip to main content
bacterial infections

Diagnostic Tools for Mitigating Bacterial Infections

Bacterial Infections

Healthcare providers need diagnostic tools that identify bacterial infections promptly to ensure effective and targeted interventions for improved patient outcome. bioMérieux provides a complete range of solutions to identify the causative agents that support more targeted therapy options and informed patient treatment decisions.  

Understanding Bacterial Infections and Antimicrobial Resistance (AMR)

Harmful bacteria enter the body and multiply, leading to bacterial infections. These infections can occur in different parts of the body and range in severity from easily treatable to life-threatening.  

When determining an appropriate treatment plan for a patient, it is imperative that a physician can accurately identify the causative pathogen to determine whether an infection is bacterial or viral. Traditional testing methods are often slow, and a physician might prescribe antibiotics empirically while awaiting results – particularly in high-risk cases such as instances of suspected meningitis and sepsis. If the infection is viral, antibiotics should never be used. It is important to note that empiric prescribing can contribute to unnecessary antibiotic use or overuse which is the main driver for the growing pandemic of antimicrobial resistance (AMR).1  

Bacterial infections can be treated with antibiotics, specifically designed to kill or inhibit the growth of bacteria. Antibiotics work by targeting bacterial cell structures or functions. Antibiotic resistance continues to emerge, and some bacterial strains may be resistant to certain antibiotics making them more difficult to treat. One way to mitigate the emergence of AMR is through initiatives that support the appropriate use of antimicrobials such as Antimicrobial Stewardship Programs (ASPs). 

Optimizing antibiotic use is critical to preserve use now and in the future, effectively treat infections, and combat AMR.The symptoms of bacterial infections can vary, and laboratory tests are needed to determine the specific cause of an infection. bioMérieux solutions equip the microbiology laboratory with the diagnostic tools needed to accurately identify the patient’s cause of infection.

  

Bacterial Infections – Our Diagnostic Offer

bioMérieux is a world leader in microbiology and for over 60 years has been providing labs worldwide with a wide range of manual and automated products as well as services and solutions to detect and identify bacterial infections. 

Our diagnostic offer for bacterial infections is designed to support medical decisions in your institution to:

  • Ensure optimal patient outcomes and avoid unnecessary antibiotic use
  • Select the most appropriate treatment
  • Personalize treatment duration to limit use of broad-spectrum antibiotics, avoid adverse side effects and discontinue antibiotics as early as possible

Disclaimer: Product availability varies by country. Please consult your local bioMérieux representative for product availability in your country. 

Culture strongly contributes to the quality and reliability of microbiology results for better patient management. For example, a direct MDRO and identification medium for correct patient isolation, ensures prompt adherence to HAI guidelines to prevent MDRO spread. Additionally, if you employ isolation and identification media specifically tailored for major pathogens, you can adjust treatment instead of conducting a full AST. 

bioMérieux provides the largest ready-to-use chromogenic media to help labs in their daily practices, quality, and operations management. CHROMID® media are state-of-the-art media for better specificity, sensitivity, and recovery of most clinical pathogens.

Differentiate, confirm, and identify microorganisms with confidence to provide fast, accurate results and support your antimicrobial stewardship goals.

Of all the laboratory examinations performed daily by clinical microbiologists, antimicrobial susceptibility testing is of particular clinical importance. AST is a critical aid for selecting the most appropriate antimicrobial therapy for individual patients, monitoring the evolution of microbial resistance, and updating empirical therapeutic strategies. 

 

Syndromic infectious disease diagnostics using BIOFIRE® Panels  can help take the guesswork out of pathogen identification. Syndromic testing combines several potential targets into one rapid diagnostic test. Fast sample-to-answer turnaround combined with comprehensive menus helps inform timely optimal therapy.

Useful Resources for Bacterial Infection Diagnostics

bacterial vs viral infections

Bacterial vs. Viral Infections

bacterial vs viral infections

BIOFIRE® Panels Brochure

bacterial vs viral infections

BIOFIRE® Panels Brochure - plus version

  

      

    References:

    1.     Dadgostar P. Antimicrobial Resistance: Implications and Costs. Infection and Drug Resistance. 2019;12(12):3903-3910. doi: https://doi.org/10.2147/idr.s234610

    2.     CDC. Core elements of hospital antibiotic stewardship programs. Centers for Disease Control and Prevention. Published 2019. https://www.cdc.gov/antibiotic-use/hcp/core-elements/hospital.html